Abstract
Extant data, mostly from studies in vitro, suggest that coumarin and nicotine are both metabolized by CYP2A6, a cytochrome P450 isozyme. In order to investigate this issue further, the activity of this enzyme in vivo was measured in 37 non-smokers and 37 smokers using coumarin (2.0 mg, PO) as the metabolic probe. The percentage of coumarin metabolized to 7-hydroxycoumarin in 8 h was measured in urine by high-pressure liquid chromatography. There was more than 10-fold variability in coumarin metabolism in both groups. Coumarin metabolism was significantly reduced in smokers (46.6±4.4%) as compared to non-smokers (66.4±3.5%; p≤.001). The results support previous in vitro findings that both coumarin and nicotine are metabolized, at least in part, by a common pathway, which most likely is CYP2A6.
Original language | English (US) |
---|---|
Pages (from-to) | 351-354 |
Number of pages | 4 |
Journal | Nicotine and Tobacco Research |
Volume | 2 |
Issue number | 4 |
DOIs | |
State | Published - Jan 1 2000 |
Externally published | Yes |
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health